The Impact of COVID-19 Pandemic Restrictions on Musculoskeletal Pathology Services

Ayşe Nur Toksöz Yıldırım1, Tulay Zenginkinet2, Erhan Okay3

  • 1Pathology, Göztepe Research and Training Hospital, Istanbul, TUR.

Cureus
|June 26, 2023
PubMed

Insights

The COVID-19 pandemic impacted musculoskeletal pathology services, reducing benign lesions and tumor surgeries. However, bone and soft tissue biopsies remained feasible, indicating resilience in diagnostic procedures during health crises.

Area of Science:

  • Pathology
  • Oncology
  • Public Health

Background:

  • The COVID-19 pandemic disrupted healthcare, particularly in musculoskeletal pathology.
  • No standardized protocols existed for pathology services during the pandemic.
  • Tertiary centers in developing countries faced unique challenges.

Purpose of the Study:

  • To evaluate the impact of COVID-19 restrictions on musculoskeletal pathology workload.
  • To identify collaboration challenges between pathology and orthopedic oncology units.
  • To assess service delivery in a developing country's tertiary care setting.

Main Methods:

  • Retrospective review of pathology reports.
  • Data collected from mid-March to mid-June across 2019, 2020, and 2021.
  • Comparison of workload metrics between pandemic and non-pandemic periods.

Main Results:

  • Significant decrease in benign bone/soft tissue lesions and tumor surgeries during the pandemic (2020).
  • No significant reduction observed in biopsy procedures during the pandemic.
  • Biopsies for bone and soft tissue lesions were feasible without anesthesia during the pandemic.

Conclusions:

  • Musculoskeletal pathology services demonstrated adaptability during the COVID-19 pandemic.
  • Biopsy procedures for bone and soft tissue lesions remained viable.
  • Collaboration hurdles with orthopedic oncology require further investigation.
Abstract